GASTRIC CARCINOMA

Clinical trials for GASTRIC CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GASTRIC CARCINOMA trials appear

Sign up with your email to follow new studies for GASTRIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 14 Not yet recruiting 1 Not yet finished but already full! 7 Completed 3

New antibody drug aims to turn immune cells against cancer

Disease control Not yet recruiting

This early-stage study tests a new drug called NPX372 in people with advanced solid tumors that have not responded to standard treatments. The drug is designed to help the body's immune cells recognize and attack cancer cells. The main goals are to check the drug's safety and fin…

Matched conditions: GASTRIC CARCINOMA

Phase: PHASE1 • Sponsor: NextPoint Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC

GASTRIC CARCINOMA

Get alerted when new GASTRIC CARCINOMA trials appear

New antibody drug aims to turn immune cells against cancer